{
    "clinical_study": {
        "@rank": "82130", 
        "arm_group": {
            "arm_group_label": "lidocaine", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "Prospective, monocentric, open-label study conducted in women requiring mastectomy and\n      eligible for tumescent infiltrative anaesthesia.\n\n      Blood samples will be collected during 48h after start of infiltration. Total and free\n      lidocaine concentrations measurements will be determined by gas chromatography. Visual\n      analogic scale scores to evaluate postoperative pain and all data concerning analgesic drugs\n      and adverse effects will be collected.\n\n      Population pharmacokinetic parameters will be estimated using NONMEM software and covariates\n      influence on parameters variability will be tested.\n\n      Primary outcome value: Population pharmacokinetic parameters with possible covariates\n      influence on variability.\n\n      Patients and period of study: n=30 patients enrolled during 24 months, total study duration:\n      30 months."
        }, 
        "brief_title": "Lidocaine Pharmacokinetics During Tumescent Infiltrative Anaesthesia for Mastectomy", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Mastectomy", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Surgery carcinologique of the breast requiring a mastectomy under tumescente local\n             anesthetic\n\n          -  Age: upper to 18 years\n\n          -  Weight: upper to 50 kg\n\n        Exclusion Criteria:\n\n          -  Cutaneous infection in the point of draining\n\n          -  Clinical Disorder(Confusion) of the coagulation\n\n          -  Retreat(Withdrawal) of the consent in the course of protocol\n\n          -  Unwanted Effect engraves(burns) requiring the stop(ruling) of the\n             treatment(processing)"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 20, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01687348", 
            "org_study_id": "2012-000817-36", 
            "secondary_id": "2012-05"
        }, 
        "intervention": {
            "arm_group_label": "lidocaine", 
            "intervention_name": "lidocaine aguettant", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Anesthetics", 
                "Lidocaine"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "September 17, 2012", 
        "location": {
            "contact": {
                "email": "bernard.bruguerolle@ap-hm.fr", 
                "last_name": "bernard bruguerolle"
            }, 
            "facility": {
                "address": {
                    "city": "Marseille", 
                    "country": "France", 
                    "zip": "13354"
                }, 
                "name": "Assistance Publique Hopitaux de Marseille"
            }, 
            "investigator": {
                "last_name": "bernard bruguerolle", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "1", 
        "official_title": "Lidocaine Pharmacokinetics During Tumescent Infiltrative Anaesthesia for Mastectomy.", 
        "overall_contact": {
            "email": "bernard.bruguerolle@ap-hm.fr", 
            "last_name": "Bernard bruguerolle"
        }, 
        "overall_official": {
            "affiliation": "Assistance Publique h\u00f4pitaux de Marseille", 
            "last_name": "BERNARD BELAIGUES", 
            "role": "Study Director"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "France: Afssaps - Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9 (Saint-Denis)", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "during tumescent infiltrative anaesthesia for mastectomy.", 
            "measure": "Peak Plasma Concentration (Cmax) of 'drug lidocaine'\"", 
            "safety_issue": "No", 
            "time_frame": "36 MONTHS"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01687348"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "analgesic postoperative efficacy", 
            "safety_issue": "No", 
            "time_frame": "36 MONTHS"
        }, 
        "source": "Assistance Publique Hopitaux De Marseille", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Assistance Publique Hopitaux De Marseille", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2012", 
        "study_design": "Endpoint Classification: Pharmacokinetics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2012"
    }
}